Genetic testing for familial hypercholesterolaemia: utility beyond diagnosis

Eur J Prev Cardiol. 2024 May 11;31(7):e59-e61. doi: 10.1093/eurjpc/zwac258.

Authors

Margherita Bigossi^{1

2}, Moneeza K Siddiqui¹

Affiliations

¹ Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Population Health and Genomics, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK.
² Section of Internal Medicine and Thromboembolic Diseases, Department of Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.

PMID: 36356117
DOI: 10.1093/eurjpc/zwac258

No abstract available

Publication types

Editorial
Comment

MeSH terms

Genetic Predisposition to Disease*
Genetic Testing* / methods
Humans
Hyperlipoproteinemia Type II* / diagnosis
Hyperlipoproteinemia Type II* / genetics
Mutation
Phenotype
Predictive Value of Tests